Wockhardt Gets FDA Approval for Marketing Generic Aricept

by Kathy Jones on  April 25, 2011 at 5:46 PM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

Mumbai based pharmaceutical company, Wockhardt has revealed that it has got a tentative approval from the US Food and Drug Administration to market its generic copy of Aricept tablets used in treatment of Alzheimer's and dementia.
 Wockhardt Gets FDA Approval for Marketing Generic Aricept
Wockhardt Gets FDA Approval for Marketing Generic Aricept

Wockhardt said that it expects to launch the Donepezil HCl tablets by May 8 this year and added that the approval has been given for 5 mg and 10 mg versions of the tablet.

The company is confident of getting a substantial slice of the $2.5 billion market that the drug commands in the US.

"We are continuing to get a steady stream of FDA approval and are able to launch them on the date the generic market opportunity opens", the company chairman, Mr Habil Khorakiwala said.


Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Donepezil HCl tablets for Alzheimer’s and dementia - is this for India or just for USA.

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive

Loading...